Hope Rugo, MD
Enriched profileDirector, Women's Cancers Program; Division Chief, Breast Medical Oncology; Professor, Department of Medical Oncology & Therapeutics Research · City of Hope
Hope Rugo is Director, Women's Cancers Program; Division Chief, Breast Medical Oncology; Professor, Department of Medical Oncology & Therapeutics Research at City of Hope. OpenAlex indexes 1,607 publications with 103,502 citations (h-index 140); ClinicalTrials.gov lists 30 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Hematology profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Hope Rugo, MD, is Director, Women's Cancers Program at City of Hope (Beckman Research Institute / City of Hope Comprehensive Cancer Center, Duarte, CA). The public record shows 1,607 publications with 103,502 citations (h-index 140), centered on Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research. It also documents an investigator role on 30 registered clinical trials, industry payments reported by 34 companies, 2 NIH-funded awards (2004–2023).
- Most recent indexed publication: 2026 · Cardio-oncology (London, England)
- Top research focus: Advanced Breast Cancer Therapies
- 30 registered trials on ClinicalTrials.gov
- Open Payments reporting from 34 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 109 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 613.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 30 registered studies on ClinicalTrials.gov. The most recent:
- A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Sponsor: NiKang Therapeutics, Inc.
Industry payments
Updated 27 Aug 2026
34 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year202520 payments$21,972openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202513 payments$16,218openpaymentsdata.cms.gov ↗
- Napo Pharmaceuticals IncProgram year20257 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
63.2%Aromatase Inhibitor40.7%Letrozole72%Exemestane17%Anastrozole10%Part D<11 patientsKinase inhibitor12.1%Kisqali100%Part D<11 patientsNervous system
23.3%Atypical Antipsychotic9%Olanzapine100%Part D<11 patientsGabapentinoids7%Gabapentin100%Part D<11 patientsMetabolism & gastrointestinal
6.5%Serotonin-3 Receptor Antagonist6.5%Ondansetron Hcl100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2004–2023 per NIH RePORTER. The latest:
- Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia
Cooler Heads Care Inc
FY2023$1,036,917R44CA254560 - AG-013736 WITH DOCETAXEL VS DOCETAXEL ALONE IN METASTATIC BREAST CANCER
University of California San Francisco
FY2005$4,209M01RR000079 - AG-013736 With Docetaxel Vs Docetaxel Alone in Metastatic Breast Cancer
University of California San Francisco
FY2004$2,129M01RR000079
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.
Clinical cancer research
Article2026
Most-cited works
by citation count (OpenAlex)- 01Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer4,374 citations2018
- 02Palbociclib and Letrozole in Advanced Breast Cancer2,953 citations2016
- 03
- 04
- 05Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer2,561 citations2022
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/hope-rugo-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - X / Twitter
x.com/hoperugo
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/DP8dyRiAHrc
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/posts/city-of-hope_dr-hope-s-rugo-breast-cancer-awareness-activity-7382165654159769600-0HNE
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/city-of-hope_we-are-excited-to-share-hope-s-rugo-md-activity-7318309503492382721--_Hs
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Residency
Internal Medicine and Primary Care, UCSF
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Fellowship
Hematology and Oncology, UCSF
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
- Co-Chair
Triple Negative Working Group, Translational Breast Cancer Research Consortium (TBCRC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →anixa.com ↗ - Investigator and Chair of Safety Committee
I-SPY2 trial
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsfhealthhemonc.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- Member
Breast Cancer Clinical Advisory Board, Anixa Biosciences, Inc.
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →anixa.com ↗ - Investigator
Breast Cancer Research Foundation (BCRF)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podchaser.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Ito, MD
City of Hope
Victoria Seewaldt
City of Hope
Dean Lim, MD
City of Hope
Ahmed Aribi, MD
City of Hope